Aurobindo Pharma Limited (BOM: 524804)

Market Cap	721.18B
Revenue (ttm)	302.95B
Net Income (ttm)	35.82B
Shares Out	n/a
EPS (ttm)	61.31
PE Ratio	20.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,561
Open	1,254.00
Previous Close	1,255.40
Day's Range	1,235.15 - 1,274.70
52-Week Range	959.05 - 1,592.55
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 7, 2025

About Aurobindo Pharma

Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibi...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Employees: 26,015
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524804

Financial Performance

In 2023, Aurobindo Pharma's revenue was 290.02 billion, an increase of 16.68% compared to the previous year's 248.55 billion. Earnings were 31.73 billion, an increase of 64.62%.